Our latest news

Fitabeo Therapeutics and TSP Therapeutics enter strategic partnership to develop cancer treatments

August 25, 2025

Fitabeo Therapeutics Secures Patent for Innovative Drug Delivery Technology

August 20, 2024

Advancements in the Fight Against Alzheimer’s Disease

May 14, 2024

Fitabeo Therapeutics secures prestigious win at Scottish Edge!

Exciting News Alert! Fitabeo Wins Scottish Edge!

November 30, 2023

Who’s really in charge of pharmaceutical pricing in the US?

A closer look at the role of PBMs and pharmacies.

May 5, 2023

Alex Mullen on The Medicine Maker’s 2023 Power List!

We seek inspiration from your vision of providing patients with #enhanced #qualityoflife. Thank you for making us all part of your mission Alex Mullen

April 25, 2023

Fitabeo Therapeutics to present at LSX World Congress Biotech…

We are excited to announce that we are presenting at Biotech Showcase, the LSX World Congress.

April 24, 2023

Fitabeo Therapeutics Spins Out From Strathclyde Uni

Edinburgh clinical-stage specialty pharmaceutical company Fitabeo Therapeutics has spun-out from the University of Strathclyde and said it plans “to address some of society’s most pressing healthcare challenges within chronic pain and women’s health.”

December 22, 2022

Strathclyde spinout to provide solutions for healthcare challenges

Fitabeo Therapeutics has ‘spun-out’ from the University of Strathclyde with plans to address some of society’s most pressing healthcare challenges within chronic pain and women’s health.

December 15, 2022